- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Endometrial Cancers With FGFR2 Mutations in United Kingdom
Total 1023 results
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Endometrial CancerUnited States
-
Columbia UniversityAmerican Cancer Society, Inc.CompletedBreast Cancer | Ovarian Cancer | BRCA1 Mutation | BRCA2 MutationUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia With FLT3/ITD MutationUnited States
-
National Cancer Institute (NCI)CompletedTherapy-Related Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | FLT3 Gene Mutation | Acute Promyelocytic Leukemia With PML-RARA | Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1United States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedStage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous AdenocarcinomaUnited States
-
Washington University School of MedicineCompletedEndometrial CancerUnited States
-
Yale UniversityMerck Sharp & Dohme LLCActive, not recruitingRecurrent Endometrial CancerUnited States
-
Deciphera Pharmaceuticals LLCRecruitingMelanoma | Non-Small Cell Lung Cancer | Advanced Solid Tumor | Pancreatic Ductal Adenocarcinoma | BRAF Gene Mutation | RAS Mutation | NF1 Mutation | RAF Mutation | CRAF Gene MutationUnited States
-
WellSpan HealthActive, not recruitingRecurrent Endometrial CarcinomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedEndometrial CancerUnited States
-
University of Medicine and Dentistry of New JerseyTerminated
-
Dana-Farber Cancer InstitutePfizerActive, not recruiting
-
Steven J Isakoff, MD, PhDDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; AbbottActive, not recruitingBreast Cancer | Metastatic Breast Cancer | BRCA1 Gene Mutation | brca2 Gene MutationUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast Cancer | Endometrial CancerUnited States
-
Novartis PharmaceuticalsWithdrawnEndometrial CancerUnited States, Russian Federation, Germany, Singapore, Italy, Spain, France, Brazil, Canada, Japan, Poland, Turkey
-
Teresa MeierRecruitingEndometrial CancerUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterTerminated
-
Precision TherapeuticsCompletedEndometrial CancerUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI); Clovis Oncology, Inc.Active, not recruitingMetastatic Endometrial CancerUnited States
-
University of OklahomaImmunoGen, Inc.WithdrawnEndometrial Cancer | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial AdenocarcinomaUnited States
-
Massachusetts General HospitalUnknownCervical Cancer | Ovarian Cancer | Endometrial CancerUnited States
-
WellSpan HealthRecruitingEndometrial CancerUnited States
-
Frederick R. Ueland, M.D.CompletedEndometrial CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
University of Wisconsin, MadisonCompleted
-
University of VirginiaCompletedEndometrial CancerUnited States
-
Northwestern UniversityCompletedCervical Cancer | Gynecologic Cancer | Ovarian Cancer | Endometrial Cancer | Uterine CancerUnited States
-
University of ChicagoRecruitingMyeloproliferative Neoplasm | Blood Cancer | IDH2 Gene Mutation | IDH1 Mutation | IDH MutationUnited States
-
Mayo ClinicCompletedMyeloma Before MV-NIS Treatment | Endometrial Cancer Before VSV-hINF-NIS TreatmentUnited States
-
Hoffmann-La RocheNo longer availableCancers With RET AlterationsUnited States
-
University of ArkansasCompletedEndometrial CancerUnited States
-
University of California, San DiegoCardinal Health 414, LLCTerminatedEndometrial CancerUnited States
-
Swedish Medical CenterCompletedEndometrial CancerUnited States
-
University of OklahomaCompletedEndometrial Cancer | Papillary Serous | Clear Cell Endometrial CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedEndometrial Clear Cell Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Recurrent Uterine Corpus CancerUnited States
-
Maximilian Stahl, MDSyndax PharmaceuticalsNot yet recruitingAcute Myeloid Leukemia | Leukemia | AML | AML, Adult | AML With Gene MutationsUnited States
-
National Cancer Institute (NCI)CompletedTriple Negative Breast Cancer | Endometrial Cancer | Hormone Receptor Positive, HER2 Negative Breast CancerUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Northwestern UniversityActive, not recruitingPhysical Activity | Breast Cancer Survivors | Endometrial Cancer SurvivorsUnited States
-
UNC Lineberger Comprehensive Cancer CenterCompletedEndometrial CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterWilma Williams Education and Clinical Research for Endometrial Cancer AwardCompletedEndometrial CancerUnited States
-
Stanford UniversityNational Cancer Institute (NCI)CompletedCervical Cancer | Endometrial Cancer | Radiation Toxicity | Vaginal CancerUnited States
-
Stanford UniversityRecruitingCervix Cancer | Endometrial CancerUnited States
-
University of Wisconsin, MadisonCompleted
-
Seagen Inc.GenmabCompletedProstate Cancer | Squamous Cell Carcinoma of the Head and Neck | Bladder Cancer | Cervix Cancer | Lung Cancer, Nonsmall Cell | Ovary Cancer | Esophagus Cancer | Endometrium CancerUnited States, United Kingdom
-
Ohio State University Comprehensive Cancer CenterCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProgressive Disease | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Carcinoma | Endometrial Adenocarcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Platinum-Resistant Ovarian Carcinoma | High Grade Ovarian... and other conditionsUnited States
-
Endeavor Biomedicines, Inc.Active, not recruitingSolid Tumors With PTCH1 Loss-of-function MutationsUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedStage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial AdenocarcinomaUnited States
-
Case Comprehensive Cancer CenterCompletedObesity | Uterine Cancer | Stage I Endometrial AdenocarcinomaUnited States
-
PharmaMarTerminatedEndometrial Cancer | Uterine Cervical CancerUnited States